Cargando…

Active induction of experimental autoimmune encephalomyelitis by MOG(35-55) peptide immunization is associated with differential responses in separate compartments of the choroid plexus

BACKGROUND: There is increasing awareness that, aside from producing cerebrospinal fluid, the choroid plexus (CP) might be a key regulator of immune activity in the central nervous system (CNS) during neuroinflammation. Specifically, the CP has recently been posited to control entry of sentinel T ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murugesan, Nivetha, Paul, Debayon, Lemire, Yen, Shrestha, Bandana, Ge, Shujun, Pachter, Joel S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493354/ https://www.ncbi.nlm.nih.gov/pubmed/22870943 http://dx.doi.org/10.1186/2045-8118-9-15

Ejemplares similares

The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis
por: Ge, Shujun, et al.
Publicado: (2012)

Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide
por: Buerth, Christoph, et al.
Publicado: (2016)

Characterization of myelin oligodendrocyte glycoprotein (MOG)(35–55)-specific CD8(+) T cells in experimental autoimmune encephalomyelitis
por: Peng, Yong, et al.
Publicado: (2019)

Soluble MOG35-55/I-A(b) Dimers Ameliorate Experimental Autoimmune Encephalomyelitis by Reducing Encephalitogenic T Cells
por: Gong, Yeli, et al.
Publicado: (2012)

Arg Deficiency Does not Influence the Course of Myelin Oligodendrocyte Glycoprotein (MOG35-55)-induced Experimental Autoimmune Encephalomyelitis
por: Jacobsen, Freja Aksel, et al.
Publicado: (2016)

Myelin Oligodendrocyte Glycoprotein (MOG(35-55)) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
por: Bittner, Stefan, et al.
Publicado: (2014)

Myelin oligodendrocyte glycoprotein (MOG(35-55))-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice
por: Yun, Jaesuk, et al.
Publicado: (2015)

Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG(35-55)-induced experimental autoimmune encephalomyelitis
por: Wetzel, Lisa A., et al.
Publicado: (2020)

Cell-selective knockout and 3D confocal image analysis reveals separate roles for astrocyte-and endothelial-derived CCL2 in neuroinflammation
por: Paul, Debayon, et al.
Publicado: (2014)

Infusion of Sulfosuccinimidyl-4-[N-maleimidomethyl]cyclohexane-1-carboxylate-Conjugated MOG(35–55)-Coupled Spleen Cells Effectively Prevents and Reverses Experimental Autoimmune Encephalomyelitis in Mice
por: Zhang, Lanfang, et al.
Publicado: (2015)

HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection
por: Benedek, Gil, et al.
Publicado: (2015)

Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions
por: Dagkonaki, Anastasia, et al.
Publicado: (2020)

Intradermal vaccination prevents anti-MOG autoimmune encephalomyelitis in macaques
por: Fovet, Claire-Maëlle, et al.
Publicado: (2019)

The choroid plexus acts as an immune cell reservoir and brain entry site in experimental autoimmune encephalomyelitis
por: Lazarevic, Ivana, et al.
Publicado: (2023)

Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis
por: Chiuso-Minicucci, Fernanda, et al.
Publicado: (2015)

Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG(35-55)-Induced EAE
por: Rajendran, Ranjithkumar, et al.
Publicado: (2021)

Histopathology and clinical course of MOG-antibody-associated encephalomyelitis
por: Spadaro, Melania, et al.
Publicado: (2015)

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
por: Jarius, S., et al.
Publicado: (2018)

Peripherally derived macrophages as major phagocytes in MOG encephalomyelitis
por: Kwon, Young Nam, et al.
Publicado: (2019)

Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis
por: Borisow, Nadja, et al.
Publicado: (2018)

Resolution of central nervous system astrocytic and endothelial sources of CCL2 gene expression during evolving neuroinflammation
por: Shrestha, Bandana, et al.
Publicado: (2014)

Correction to: The choroid plexus acts as an immune cell reservoir and brain entry site in experimental autoimmune encephalomyelitis
por: Lazarevic, Ivana, et al.
Publicado: (2023)

Correction: Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis
Publicado: (2015)

Immune Thymic Profile of the MOG-Induced Experimental Autoimmune Encephalomyelitis Mouse Model
por: das Neves, Sofia P., et al.
Publicado: (2018)

Oligodendrocyte‐specific deletion of FGFR2 ameliorates MOG(35‐55)‐induced EAE through ERK and Akt signalling
por: Kamali, Salar, et al.
Publicado: (2021)

Appearance of claudin-5(+) leukocyte subtypes in the blood and CNS during progression of EAE
por: Krajewski, Dylan, et al.
Publicado: (2021)

Experimental Autoimmune Encephalomyelitis Is Successfully Controlled by Epicutaneous Administration of MOG Plus Vitamin D Analog
por: Zorzella-Pezavento, Sofia Fernanda Gonçalves, et al.
Publicado: (2017)

Choroid plexus-selective inactivation of adenosine A(2A) receptors protects against T cell infiltration and experimental autoimmune encephalomyelitis
por: Zheng, Wu, et al.
Publicado: (2022)

Choroid plexus tumours
por: Wolff, J E A, et al.
Publicado: (2002)

Tumour of the Choroid Plexus
Publicado: (1928)

Choroid plexus papilloma
por: Sethi, Divya, et al.
Publicado: (2017)

Passive Experimental Autoimmune Encephalomyelitis in C57BL/6 with MOG: Evidence of Involvement of B Cells
por: Mannara, Francesco, et al.
Publicado: (2012)

Swimming Exercise Ameliorates Symptoms of MOG-Induced Experimental Autoimmune Encephalomyelitis by Inhibiting Inflammation and Demyelination in Rats
por: Kim, Ji-Youn, et al.
Publicado: (2020)

Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG–Associated Experimental Autoimmune Encephalomyelitis
por: Remlinger, Jana, et al.
Publicado: (2022)

Targeting transmembrane-domain-less MOG expression to platelets prevents disease development in experimental autoimmune encephalomyelitis
por: Cai, Yuanhua, et al.
Publicado: (2022)

Human ES-derived MSCs correct TNF-α-mediated alterations in a blood–brain barrier model
por: Ge, Shujun, et al.
Publicado: (2019)

AZD-1222: Acute disseminated encephalomyelitis anti-MOG antibody‑positive: case report
Publicado: (2022)

MOG-induced experimental autoimmune encephalomyelitis in the rat species triggers anti-neurofascin antibody response that is genetically regulated
por: Flytzani, Sevasti, et al.
Publicado: (2015)

Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA
por: Derdelinckx, Judith, et al.
Publicado: (2019)

Clinical, radiological, therapeutic and prognostic differences between MOG-seropositive and MOG-seronegative pediatric acute disseminated encephalomyelitis patients: a retrospective cohort study
por: Dong, Xueshan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_16ukp17pdm4mdn3euoua50e5bj